MedPath

Secura Bio, Inc.

Secura Bio, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2019-01-01
Employees
11
Market Cap
-
Website
http://securabio.com

Clinical Trials

7

Active:5
Completed:2

Trial Phases

2 Phases

Phase 1:5
Phase 2:2

Drug Approvals

4

NMPA:2
FDA:2

Drug Approvals

Duvelisib Capsules

Product Name
克必妥
Approval Number
国药准字HJ20220017
Approval Date
Mar 16, 2022
NMPA

Duvelisib Capsules

Product Name
克必妥
Approval Number
国药准字HJ20220018
Approval Date
Mar 16, 2022
NMPA

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 1
5 (71.4%)
Phase 2
2 (28.6%)
No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath